Emma Searle, MD^1,2*, James Cavet^1,2*, Victoria Campbell, MD, PhD^3*, Steve Knapper^4,5*, Ceri Bygrave, MD, FRCPath, MPhil^6*, Dima El-Sharkawi, MBBS, FRCPath, PhD^7*, Charlotte Pawlyn, MBBChir, PhD^8,9, Maria Creignou, MD^10*, Harriet Walter^11*, David Valcárcel^12*, Marta Hidalgo Soto^12*, Jenny O'Nions, MBBCh, PhD, MRCP, FRCPath^13*, Amrutha Sridhar^14*, Tomasz Knurowski, MD^15*, Karen Clegg, PhD^15*, Neil Pegg^15*, Will Henry West, PhD, MSc, MBA^15*, Debbie Haynes, BSc^15*, Kris Frese, PhD^16* and Tim Somervaille^1,2,17

¹The University of Manchester, Manchester, United Kingdom
²The Christie NHS Foundation Trust, Manchester, United Kingdom
³Department of Hematology, Western General Hospital, Edinburgh, United Kingdom
⁴Cardiff University, Cardiff, United Kingdom
⁵Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom
⁶Haematology, University Hospital Wales, Cardiff, United Kingdom
⁷The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
⁸The Institute of Cancer Research, London, United Kingdom
⁹The Royal Marsden NHS Foundation Trust, London, United Kingdom
¹⁰Phase 1 Unit, Center for Clinical Cancer Studies, Karolinska University Hospital, Stockholm, Sweden
¹¹University of Leicester and University Hospitals Leicester, Leicester, GBR
¹²Vall d’Hebron Institute of Oncology, Barcelona, Spain
¹³University College London NHS Foundation Trust, London, United Kingdom
¹⁴NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁵CellCentric Ltd, Cambridge, United Kingdom
¹⁶CellCentric Ltd, Manchester, United Kingdom
¹⁷Cancer Research UK Manchester Institute, Manchester, United Kingdom

Weijun Fu^1*, Soo-Mee Bang, MD, PhD², Honghui Huang, PhD, MD^3*, Kihyun Kim^4*, Wei Li^5*, Gang An^6*, Je-Jung Lee^7*, Zhen Cai^8*, Jie Jin^9,10,11, Yafei Wang^12*, Chor Sang Chim, MD, PhD, BMBS^13*, Paula Rodriguez Otero, MD, PhD^14*, Meletios A. Dimopoulos, MD, PhD¹⁵, Tomoaki Fujisaki^16*, Jae Hoon Lee^17*, Susan Wroblewski^18*, Fredrik Borgsten, MD^19*, Robin Carson, MD, BA¹⁸, Rui Liu^20*, Man Zhao^21*, Tingting Wu^22*, XI Chen, PhD^23*, Canchan Cui^24*, Jian Hou^3* and Jianxiang Wang, MD⁶

¹Shanghai Changzheng Hospital, Shanghai, China
²Seoul National University Bundang Hospital, Seongnam-si, KOR
³Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
⁴Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁵The First Hospital of Jilin University, Changchun, China
⁶Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁷Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Hwasun, Korea, Republic of (South)
⁸Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁹The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹⁰First Affiliated Hospital of Zhejiang University, College of Medicine, Hangzhou, Zhejiang, China
¹¹First Affiliated Hospital of Zhejiang University, College of Medicine, Hangzhou, CHN
¹²Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
¹³Hong Kong Sanatorium & Hospital, Hong Kong, China
¹⁴Clínica Universidad de Navarra, Pamplona, Spain
¹⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹⁶Matsuyama Red Cross Hospital, Matsuyama, Japan
¹⁷Gachon University Gil Medical Center, Incheon, Korea, Republic of (South)
¹⁸Janssen Research & Development, LLC, Spring House, PA
¹⁹Janssen Research & Development, LLC, Raritan, NJ
²⁰Johnson & Johnson China Ltd, Beijing, China
²¹IQVIA, Shanghai, China
²²ICON, Shanghai, China
²³Xian Janssen Pharmaceutical Ltd.; Xian Janssen Pharmaceutical Ltd., Beijing; Shanghai, China
²⁴Xian Janssen Pharmaceutical Ltd., Beijing, China

Larysa Sanchez, MD^1*, Carolina Schinke, MD², Amrita Krishnan, MD³, Jésus G Berdeja, MD⁴, Niels W.C.J van de Donk, MD, PhD^5*, María Victoria Mateos, MD, PhD⁶, Ajai Chari, MD^7*, Samir Parekh, MD⁸, Tarek H. Mouhieddine, MD⁹, Sundar Jagannath, MD⁸, Nizar J Bahlis, MD¹⁰, Cyrille Touzeau, MD, PhD^11*, Albert Oriol, MD^12*, Jesus San-Miguel, MD, PhD¹³, Paula Rodriguez Otero, MD, PhD^14*, Monique C Minnema^15*, Michela Campagna, PhD^16*, Tara J Masterson, MS^17*, Brandi W Hilder, PhD¹⁷, Jaszianne Tolbert, MD¹⁷, Thomas Renaud, MD¹⁸, Kathleen Gray^19*, Damiette Smit^20*, Christoph Heuck^17* and Leo Rasche, MD^21*

¹Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY
²Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
³Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Irvine, CA
⁴Sarah Cannon Research Institute, Nashville, TN
⁵Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
⁶University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
⁷at the time that the work was performed, Mount Sinai School of Medicine, New York, NY
⁸Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
⁹Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁰Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
¹¹Centre Hospitalier Universitaire de Nantes, Nantes, France
¹²Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
¹³Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
¹⁴Clínica Universidad de Navarra, Pamplona, Spain
¹⁵University Medical Center Utrecht, Utrecht, Netherlands
¹⁶Janssen Research & Development, Madrid, Spain
¹⁷Janssen Research & Development, Spring House, PA
¹⁸Janssen Research & Development, Raritan, NJ
¹⁹Janssen Scientific Affairs, Horsham, PA
²⁰Janssen Biologics Europe, Leiden, Netherlands
²¹University Hospital of Würzburg, Würzburg, Germany

Ellen Marin, PA-C^1*, Sara Scott, PharmD^2*, Kathryn Maples, PharmD^3*, Nisha S. Joseph, MD⁴, Craig C. Hofmeister, MD⁵, Vikas A. Gupta, MD, PhD⁵, Madhav V. Dhodapkar, MD, PhD⁵, Jonathan L. Kaufman, MD⁶, Sagar Lonial, MD^7* and Ajay K. Nooka, MD, MPH²

¹Winship Cancer Institute at Emory University Hospital, Decatur, GA
²Winship Cancer Institute, Emory University Hospital, Atlanta, GA
³Pfizer, Atlanta
⁴Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Louisville, KY
⁵Winship Cancer Institute of Emory University, Atlanta
⁶Winship Cancer Institute, Emory University, Atlanta, GA
⁷Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA

Wei-Ying Jen, MD, FRCPath, MA^1*, Melissa Ooi, PhD, FRCPath, MBBChir, MRCP^2*, Sanjay De Mel, BSc, FRCPath, MRCP^3*, Cinnie Soekojo, MRCP (UK), FRCPath^4*, Sung-Soo Yoon, MD, PhD⁵, Xinhua Li^6*, Neha Awasthi^6*, Sarah M Burkill^6*, Brian GM Durie, MD⁷ and Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP⁸

¹Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
²National University Cancer Institute, Singapore, Singapore
³National University Hospital, Singapore, SGP
⁴National University Cancer Institute, Singapore, National University Health Syst, Singapore, MD, SGP
⁵Department of Hemato-Oncology, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁶Singapore Clinical Research Institute, Singapore, Singapore
⁷Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
⁸National University Hospital National University Cancer Institute, Singapore, Singapore

Rakesh Popat^1*, Bradley Augustson^2*, Mercedes Gironella^3*, Cindy Lee^4*, Paul Cannell^5*, Nashita Patel^6*, Ravi Kasinathan^7*, Rachel Rogers^8*, Amy Curry^9*, Fernando Carreno^7*, Sumita Roy-Ghanta^7*, Joanna Opalinska^7* and Hang Quach, MD, FRACP, FRCPA, MBBS¹⁰

¹University College London, London, United Kingdom
²Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
³Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain
⁴Royal Adelaide Hospital, Adelaide, SA, Australia
⁵Department of Medicine, Royal Perth Hospital, Perth, Western Australia, Australia
⁶GSK, London, United Kingdom
⁷GSK, Upper Providence, PA
⁸GSK plc, Upper Providence, PA
⁹GSK, Durham, NC
¹⁰St. Vincent's Hospital Melbourne, East Melbourne, Australia

Noffar Bar, MD¹, Maria Victoria Mateos, MD, PhD², Paz Ribas^3*, Markus Hansson, MD, PhD^4,5*, Laura Paris^6*, Craig C. Hofmeister, MD⁷, Paula Rodriguez Otero, MD, PhD^8*, Maria Aranzazu Bermúdez^9*, Thomas Martin, MD¹⁰, Armando Santoro, MD^11,12*, Andrew J. Yee¹³, Maria Creignou, MD^14*, Cristina Encinas Rodriguez^15*, Claudio Cerchione, MD, PhD¹⁶, Javier De La Rubia^17*, Albert Oriol, MD^18*, Heidi Waibel^19*, Britta Besemer, MD^20*, Ethan Thompson, PhD^21*, Brian Kiesel^21*, Jinjie Chen^21*, Alexander Chung^21*, Isaac W. Boss^21*, Allison Gaudy^21*, Shaoyi Li^21*, Kevin Hsu^21*, Colin Godwin, MD^21*, Michael R. Burgess, MD, PhD²¹, Jesús San-Miguel, MD, PhD^8* and Luciano Costa, MD, PhD²²

¹Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Cheshire, CT
²University Hospital of Salamanca, Salamanca, Spain
³Hospital Universitario Dr Peset Aleixandre, Valencia, Spain
⁴Skane University Hospital, Lund, Sweden
⁵Sahlgrenska University Hospital, Göteborg, Sweden
⁶ASST Papa Giovanni XXIII, Bergamo, Italy
⁷Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁸Cancer Center Clínica Universidad de Navarra (CCUN), CIMA, CIBERONC, IDISNA, Pamplona, Spain
⁹Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
¹⁰University of California, San Francisco, CA
¹¹Humanitas University, Pieve Emanuele, Milan, Italy
¹²IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Rozzano, Milan, Italy
¹³Massachusetts General Cancer Center, Boston, MA
¹⁴Phase 1 Unit, Center for Clinical Cancer Studies, Karolinska University Hospital, Stockholm, Sweden
¹⁵Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain
¹⁶Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy
¹⁷University Hospital La Fe, Valencia, Spain
¹⁸Institut Josep Carreras and Institut Catala d'Oncologia, Hospital Germans Trias I Pujol, Barcelona, Spain
¹⁹Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
²⁰University Hospital of Tuebingen, Tuebingen, Germany
²¹Bristol Myers Squibb, Princeton, NJ
²²University of Alabama at Birmingham, Birmingham, AL

Masa Lasica^1,2*, Andrew Spencer, MBBS, MD, FRACP, FRCPA^3,4,5*, Noemi Horvath, MBBS, FRACP, FRCPA⁶, Wojt Janowski, FRCPA, FRACP⁷, Douglas Coghlan, FRACP, FRCPA, MBBS⁸, Craig Wallington-Gates^9*, Philip Campbell, MBBS^10,11, Hock Choong Lai, MBBS, FRACP, FRCPA^12*, Georgia McCaughan, BMedSc MBBS MMed (Clin Epi) FRACP FRCPA^13,14*, Nicholas Weber, MBBS^15*, Anish Puliyayil^16*, Philip Wong, MBBS^17*, Deng Yachao^18,19*, Khoa Le, BPharm^20,21*, John Reynolds, BSc, MSc, PhD^4,5* and Hang Quach, MD, FRACP, FRCPA, MBBS^22,23

¹Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia, Melbourne, Australia
²Department of Haematology, St Vincent’s Hospital Melbourne, Victoria, Australia, Fitzroy, VIC, Australia
³Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia
⁴Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia
⁵Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
⁶University of Sydney, Concord Clinical School, Faculty of Medicine and Health, Sydney, NSW, Australia
⁷Calvary Mater Newcastle, Waratah, NSW, AUS
⁸Flinders Medical Centre (FMC), South Australia, AUS
⁹Flinders Medical Centre, Bedford Park, Australia
¹⁰Department of Haematology, University Hospital Geelong, Barwon Health, Victoria, Australia, Geelong, VIC, AUS
¹¹Deakin University, Waurn Ponds, Geelong, Australia
¹²Department of Haematology, Townsville Hospital, Townsville, Australia
¹³Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
¹⁴The University of New South Wales, Kensington, NSW, Australia
¹⁵Department of Haematology Royal Brisbane and Women’s Hospital, Brisbane, AUS
¹⁶Border Medical Oncology and Haematology, East Albury, AUS
¹⁷Toowoomba Hospital, Toowoomba, QLD, AUS
¹⁸2Australasian Myeloma Research Consortium, Melbourne, Australia
¹⁹3Department of Haematology, Alfred Hospital, Melbourne, Australia
²⁰Australasian Myeloma Research Consortium, Melbourne, Australia
²¹Department of Haematology, Alfred Hospital,, Melbourne, Australia
²²St. Vincent's Hospital Melbourne, East Melbourne, Australia
²³Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia, Melbourne, VIC, Australia

Noa Biran, MD¹, Binod Dhakal, MD, MS^2*, Ruben Niesvizky, MD³, Suzanne Lentzsch, MD, PhD⁴, John T. McKay^5*, David H. Vesole, MD, PhD^1,6, Ajay K. Nooka, MD, MPH⁷, Barry Paul, MD, MS⁸, Parameswaran N. Hari, MD, MBBS⁹, Lisette Stork-Sloots^10*, Silvia D'Ambrosi^11*, Rowan Kuiper^11*, Martin van Vliet^11*, David S. Siegel, MD, PhD¹², Saad Z Usmani, MD¹³ and Frits van Rhee, MD, PhD¹⁴

¹Multiple Myeloma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
²BMT and Cellular Therapy, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³Division of Hematology & Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁴Division of Hematology & Oncology, Columbia University Medical Center, New York, NY
⁵Wake Forest University School of Medicine, Winston-Salem, NC
⁶Lombardi Comprehensive Cancer Center, Medstar Georgetown Medical Center, Washington, DC, DC
⁷Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁸Department of Hematologic Oncology & Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
⁹Department of Medicine, Medical College of Wisconsin, Milwaukee
¹⁰Medex15, Amsterdam, Netherlands
¹¹SkylineDx, Rotterdam, Netherlands
¹²Multiple Myeloma Division, Hackensack Univ. Med. Ctr., Hackensack, NJ
¹³Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR

Yael C. Cohen^1,2*, Tamir Shragai, MD^1,2*, Noa Lavi, MD^3*, Iuliana Vaxman, MD^4*, Evgeni Chubar, MD^5*, Moshe E Gatt, MD^6,7,8, Chezi Ganzel, MD^7,9*, Hila Magen, MD^10*, Efrat Luttwak, MD¹¹, Moshe Mittelman, MD^1,2, Inna Tzoran, MD^12*, Vladimir Vainstein, MD^13*, Noa Lowenton-Spier^2*, Natan Melamed^2*, Ella Krayzler^2*, Ilana Pereg^2* and Irit Avivi Mazza, MD^1,2*

¹Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
³Department of Hematology, Rambam Health Care Campus, Haifa, Israel, Haifa, ISR
⁴Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, MN, Israel
⁵Department of Hematology, HaEmek Medical Center, Afula, Israel
⁶Department of Hematology, Hadassah Medical Center, Jerusalem, Israel
⁷Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
⁸Hadassah University Hospital, Jerusalem, Israel
⁹Hematology Department, Shaare Zedek Medical Center, Jerusalem, Israel
¹⁰Tel-Hashomer, Chaim Sheba Medical Center, Ramat-Gan, Israel
¹¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Department of Hematology, Rambam Health Care Campus, Haifa, Israel
¹³Hadassah-Hebrew University medical center, department of hematology, Israel, Jerusalem, Israel

Isha Mol^1*, Yannan Hu, PhD^1*, Thomas W LeBlanc, MD², Joseph C Cappelleri, PhD, MPH^3*, Haitao Chu, PhD, MD^4*, Guido Nador, MD^5*, Didem Aydin, MD, PhD^6*, Alex Schepart, PharmD^4* and Patrick Hlavacek, MPH^4*

¹Cytel, Rotterdam, Netherlands
²Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
³Pfizer Inc, Groton, CT
⁴Pfizer Inc, New York, NY
⁵Pfizer, Surrey, United Kingdom
⁶Pfizer Inc, Istanbul, Turkey

Sikander Ailawadhi¹, Asher A. Chanan-Khan, MD¹, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, PhD^2*, Simon Gibbs, FRACP, FRCPA, MBBS^3*, Jack Khouri, MD⁴, Zi Chen^5*, Huanshan Guo^6*, Mingyu Li, PhD^7*, Mohammad Ahmad^7*, Cunlin Wang^7*, Dajun Yang^6,7,8* and Yifan Zhai^5,6,7

¹Mayo Clinic Florida, Jacksonville, FL
²Epworth HealthCare, Melbourne, VIC, Australia
³Epworth Freemasons; Eastern Health; and Alfred Health, Melbourne, Australia
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁵Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China
⁶Guangzhou Healthquest Pharma Co., Ltd., Guangzhou, China
⁷Ascentage Pharma Group Inc., Rockville, MD
⁸Department of Experimental Research, State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

Diana Cirstea, MD^1*, Rajib Shome, PhD¹, Joseph James Connolly^2*, Emilie Duvallet, PhD^3*, Amanda N. R. Joyce, PhD^3*, Victor Moyo, MD^3*, Kathleen Lively^1*, Gina Basinsky^2*, Andrew J. Yee, MD⁴, Cristiana Costa Chase, MD⁵, Ehsan Malek, MD⁶, Ruben Niesvizky, MD⁷, Paul G. Richardson, MD⁸ and Noopur S. Raje, MD⁴

¹Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School, Boston, MA
²Program for the Coordination and Oversight of Research Protocols, Massachusetts General Hospital Cancer Center, Boston, MA
³OncoPep, Inc, Cambridge, MA
⁴Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA
⁵Duke Blood Cancer Center, Durham, NC
⁶Case Western Reserve University, Cleveland, OH
⁷Division of Hematology & Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁸Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Fredrik Schjesvold, MD, PhD¹, Meletios A. Dimopoulos, MD, PhD², Sosana Delimpasi^3*, Pawel Robak^4*, Daniel Coriu, PhD^5*, Wojciech Maciej Legiec, MD^6*, Ludek Pour, MD^7*, Ivan Spicka^8*, Tamas Masszi^9*, Vadim Anatolievich Doronin, MD^10*, Jiri Minarik, MD¹¹, Galina Salogub^12,13*, Yulia Alexeeva^14,15*, Antonio Lazzaro^16*, Vladimir Maisnar^17*, Gabor Mikala, MD, PhD^18*, Stefan Norin, MD, PhD¹⁹, Marcus Thuresson^20*, Anna Bergan^19*, Jakob Obermüller^19*, Roman Hajek, MD²¹, Maria-Victoria Mateos²², Paul G. Richardson, MD²³ and Pieter Sonneveld, MD, PhD^24*

¹KG Jebsen Center for B Cell Malignancies,, University of Oslo, Oslo, Norway
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³General Hospital Evangelismos, Athens, Greece
⁴Medical University of Lodz, Lodz, Poland
⁵Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
⁶St. John of Dukla Oncology Center of Lublin Land, Department of Hematology and Bone Marrow Transplantation, Lublin, POL
⁷Department of Internal Medicine, University Hospital Brno, Brno, Czech Republic
⁸Charles University Hospital Kralovske Vinohrady, Prague, Czech Republic
⁹Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary
¹⁰Department, State Budget Healthcare Institution of Moscow, City Clinical Hospital #40 of Moscow Healthcare Department, Moscow, Russian Federation
¹¹Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olumouc, Czech Republic
¹²V.A. Almazov National Medical Research Centre, St. Petersburg, Russian Federation
¹³V.A. Almazov Chemotherapy of Oncohematology Diseases and Bone Marrow Transplantation Department #2, St. Petersburg, Russian Federation
¹⁴V.A. Almazov National Medical Research Centre, Saint Petersburg, RUS
¹⁵V.A. Almazov Chemotherapy of Oncohematology Diseases and Bone Marrow Transplantation Department #1, St. Petersburg, Russian Federation
¹⁶Division of Hematology and Bone Marrow Transplant Center, Hospital Guglielmo da Saliceto, PIACENZA PC, ITA
¹⁷4th Department of Medicine - Haematology, Charles University Hospital, Hradec Králové, CZE
¹⁸South-Pest Central Hospital, National Institute for Hematology and Infectious Diseases, Budapest, Hungary
¹⁹Oncopeptides AB, Stockholm, SWE
²⁰Oncopeptides AB, Stockholm, Sweden
²¹University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
²²Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain
²³Dana-Farber Cancer Institute, Boston, MA
²⁴Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Slavisa Ninkovic, MBBS^1,2, Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, PhD^3*, Nicholas Murphy^4*, Rosemary Anne Harrup^5,6*, Craig Wallington-Gates^7*, Magdalena Sobieraj-Teague^7*, M Hasib Sidiqi, MBBS, FRACP, FRCPA^8,9*, Anish Puliyayil^10*, Wojt Janowski^11*, John Reynolds, BSc, MSc, PhD^12,13*, Andrew Spencer, MBBS, MD, FRACP, FRCPA^13,14* and Hang Quach, MD, FRACP, FRCPA, MBBS^15,16

¹Faculty of Medicine, University of Melbourne, Melbourne, Australia
²Haematology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia
³Epworth HealthCare, Melbourne, VIC, Australia
⁴Haematology, Royal Hobart Hospital, Hobart, Australia
⁵Royal Hobart Hospital, University of Tasmania, Tasmania, Australia
⁶Royal Hobart Hospital, Tasmania, Australia
⁷Flinders Medical Centre, Bedford Park, Australia
⁸Department of Haematology, Fiona Stanley Hospital, Perth, Western Australia, Australia, Murdoch, Western Australia, AUS
⁹Curtin Medical School, Curtin University, Western Australia, Bentley, Western Australia, Australia
¹⁰Border Medical Oncology and Haematology, East Albury, AUS
¹¹Calvary Mater Health, Newcastle, Australia
¹²Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
¹³Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia
¹⁴Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia
¹⁵University of Melbourne, St. Vincent’s Hospital Melbourne, Melbourne, VIC, Australia
¹⁶St. Vincent's Hospital Melbourne, East Melbourne, Australia

Agoston Gyula Szabo, MD^1,2, Jonathan Thorsen^3*, Niels Abildgaard⁴ and Torben Plesner, MD^5*

¹Department of Hematology, Vejle Hospital, Humlebæk, Denmark, Denmark
²Department of Hematology, Rigshospitalet, Copenhagen, Denmark
³Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark
⁴Haematology Research Unit, Department of Haematology, Odense University Hospital, Odense, Denmark
⁵Vejle Hospital, Vejle, Denmark

Meletios A. Dimopoulos¹, Ola Landgren, MD², David S. Siegel, MD, PhD³, Sebastian Grosicki, MD, PhD^4*, Albert Oriol^5*, Rani Najdi^6*, Chuang Li, MD^7*, Khalid Mezzi^8*, Natalie Shu^9* and Hang Quach, MD, FRACP, FRCPA, MBBS¹⁰

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
²Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
³Multiple Myeloma Division, Hackensack Univ. Med. Ctr., Hackensack, NJ
⁴Department of Hematology and Cancer Prevention, Faculty of Health Sciences, Medical University of Silesia, Katowice, Poland
⁵Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁶Amgen Inc., Thousand Oaks, CA
⁷Amgen Inc, Thousand Oaks, CA
⁸Amgen Inc., Thousand Oaks
⁹Paraxel, Chengdu, China
¹⁰St. Vincent's Hospital Melbourne, East Melbourne, Australia

Noa Biran, MD¹, David H. Vesole, MD, PhD¹, Harsh Parmar, MBBS¹, Pooja Phull, MD^1*, Kimberly Doucette, MD, MSC^2*, Rena Feinman, PhD³, Joshua Zenreich^4*, Palka Anand, BSN^4*, Kristin Ivanovski, RN^4*, Monique Pace, RN^4*, Lisa Biamonte^4*, Martha Campanaro^4*, Trina McClendon^4*, Chandani Limbad, PhD^4*, Samanta BaboolallAracena^4*, Adolfo Aleman, MD, CCRP^1*, Rashmi Unawane, MBBS^4*, Elizabeth Pendergrass^2*, Marie Layton, MBA^4*, Genevieve Breeze, BSN^4*, Aimee Chappell, NP^2*, Alexandra Della Pia, PharmD^5*, Susan Kumka, RN, MSN, APN-C^4* and David S. Siegel, MD, PhD⁶

¹Multiple Myeloma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
²MedStar Georgetown University Hospital, Washington, DC
³Center for Discovery & Innovation, Hackensack Meridian Health, Nutley, NJ
⁴John Theurer Cancer Center, Hackensack, NJ
⁵John Theurer Cancer Center, Towaco, NJ
⁶Multiple Myeloma Division, Hackensack Univ. Med. Ctr., Hackensack, NJ

Hang Quach, MD, FRACP, FRCPA, MBBS^1,2, Masa Lasica^2,3*, Michael Low^4*, Peter Mollee, FRACP, MBBS, MSc, FRCPA^5,6, Hock Choong Lai, MBBS, FRACP, FRCPA^7*, Nicole Wong Doo, MBBS, MD, FRACP, FRCPA^8,9, Jay Hocking, MBBS, FRACP, FRCPA, PhD^10*, Philip Campbell, MBBS¹¹, Nicholas E. Murphy, MBBS, FRACP, FRCPA^12*, M Hasib Sidiqi, MBBS, FRACP, FRCPA^13,14*, David Routledge, BSc, MBChB, MSc, PGCert, MRCP UK, FRCPath UK, FRACP^15,16,17, Jessica Heenan, MBBS, FRACP, FRCPA^18*, Noemi Horvath, MBBS, FRACP, FRCPA¹⁹, Richard Eek, MBChB, MMed^20*, William E. P. Renwick, MBBS^2,21, Douglas Stuart Lenton, MBBS, FRACP, FRCPA^22*, Lauren J Child, MBChB, RACP, RCPA^23*, Georgia McCaughan, BMedSc MBBS MMed (Clin Epi) FRACP FRCPA^24*, Belinda E Butcher, PhD^25,26*, Deepmala Mazumdar, PhD^27* and Anna Kalff, MBBS, FRACP, FRCPA^28,29

¹Department of Haematology, St Vincent’s Hospital Melbourne, Victoria, Australia, Melbourne, VIC, Australia
²Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia, Melbourne, VIC, Australia
³Department of Haematology, St Vincent’s Hospital Melbourne, Victoria, Australia, Fitzroy, VIC, Australia
⁴Monash Haematology, Monash University, Clayton University, Victoria, Australia
⁵Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia
⁶Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia
⁷Townsville Cancer Centre, Townsville Hospital, Queensland, Australia, Townsville, QLD, Australia
⁸Department of Haematology, Concord Hospital, University of Sydney, New South Wales, Australia, Concord, NSW, AUS
⁹Concord Clinical School, Faculty of Medicine and Health, University of Sydney, Australia, Concord, NSW, Australia
¹⁰Department of Clinical Haematology, Austin Health, Victoria, Australia, Melbourne, VIC, Australia
¹¹Department of Haematology, University Hospital Geelong, Barwon Health, Victoria, Australia, Geelong, VIC, AUS
¹²Department of Haematology, Royal Hobart Hospital, Tasmania, Australia, Hobart, TAS, AUS
¹³Department of Haematology, Fiona Stanley Hospital, Perth, Western Australia, Australia, Murdoch, Western Australia, AUS
¹⁴Curtin Medical School, Curtin University, Western Australia, Bentley, Western Australia, Australia
¹⁵Department of Clinical Haematology, Peter MacCallum Cancer Centre, Victoria, Australia, Melbourne, VIC, Australia
¹⁶Department of Clinical Haematology, The Royal Melbourne Hospital, Victoria, Australia, Melbourne, VIC, Australia
¹⁷Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia, Melbourne, VIC, Australia
¹⁸Department of Haematology, Holman Clinic, Launceston General Hospital, Tasmania, Australia, Launceston, TAS, Australia
¹⁹Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital, South Australia, Adelaide, Sa, AUS
²⁰Department of Haematology, Border Medical Oncology, New South Wales, Australia, Wodonga, AUS
²¹Haematology Oncology, Western Health, Victoria, Australia, Melbourne, AUS
²²Department of Haematology, Orange Hospital, New South Wales, Australia, Orange, NSW, AUS
²³Auckland Regional Blood and Cancer Service, Auckland City Hospital, Auckland, New Zealand, Auckland, New Zealand
²⁴Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
²⁵School of Biomedical Sciences, UNSW, UNSW Sydney, NSW, Australia, Sydney, NSW, Australia
²⁶WriteSource Medical Pty Ltd, Lane Cove, NSW, Australia, Lane Cove, Australia
²⁷Australasian Leukaemia & Lymphoma Group, Victoria, Australia, Melbourne, VIC, Australia
²⁸Department of Clinical Haematology, Monash Medical Centre, Clayton, Victoria, Australia, Melbourne, VIC, Australia
²⁹Malignant Haematology and Stem Cell Transplantation Services, Alfred Hospital, Melbourne, Victoria, Australia, Prahran, VIC, AUS

Eric Jurgens, MD¹, Ross Firestone, MD, PhD², Kylee H Maclachlan, MBChB, PhD³, David Nemirovsky, MS^4*, Andriy Derkach, PhD^4*, Malin Hultcrantz, MD, PhD¹, Hani Hassoun, MD³, Sham Mailankody, MBBS³, Urvi A Shah, MD³, Sridevi Rajeeve, MD³, Dhwani Patel, MD^3*, Tala Shekarkhand, MS^3*, Colin Rueda^3*, Yanming Zhang, M.D.⁵, Oscar Boutros Lahoud⁶, Gunjan L. Shah⁶, Michael Scordo⁷, David Chung, MD, PhD⁷, Heather Landau, MD⁶, Sergio A. Giralt, MD, FACP⁸, Alexander Lesokhin, MD³, Neha Korde, MD³, Saad Z Usmani, MD² and Carlyn Tan, MD¹

¹Myeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY